Ovarian, peritoneal, and endometrial serous carcinoma: Clonal origin of multifocal disease

Modern Pathology

Volumn 9, Issue 3, 1996, Pages 166-173

  Kupryjanczyk, Jolanta ^b   Thor, Ann D ^b   Beauchamp, Roberta ^b   Poremba, Christopher ^b   Scully, Robert E ^b   Yandell, David W ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Clonality; Endometrial polyp; Mutation; Ovary; P53 gene; Peritoneum; Serous carcinoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CELL CLONE; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MULTIPLE CANCER; OVARY CARCINOMA; PERITONEUM CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0029866302     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Levine AJ, Momand J: Tumor suppressor genes: The p53 and retinoblastoma sensitivity genes and gene products. Biochim Biophys Acta 1032:119, 1990.
2. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453, 1991.
3. Shay JW, Werbin H, Funk WD, Wright WE: Cellular and molecular advances in elucidating p53 function. Mutat Res 277:163, 1992.
4. Finlay CA, Hinds PW, Tan TH, et al.: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531, 1988.
5. Kraiss S, Spiess S, Reihsaus E, Montenarh M: Correlation of metabolic stability and altered quaternary structure of oncoprotein p53 with cell transformation. Exp Cell Res 192: 157, 1991.
6. Marshall CHJ: Tumor suppressor genes. Cell 64:313, 1991.
7. Milner J, Medcalf EA, Cook AC: Tumor suppressor p53: Analysis of wild-type and mutant p53 complexes. Mol Cell Biol 11:12, 1991.
8. Kupryjanczyk J, Thor A, Beauchamp R, et al.: p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci U S A 90:4961, 1993.
9. Young RH, Scully RE: Pathology of epithelial tumors. Hematol Oncol Clin North Am 6:739, 1992.
10. Fromm G-L, Gershenson DM, Silva EG: Papillary serous carcinoma of the peritoneum. Obstet Gynecol 75:89, 1990.
11. Daya D, McCaughey WTE: Pathology of the peritoneum: A review of selected topics. Semin Diagn Pathol 8:277, 1991.
12. Mills SE, Andersen WA, Fechner RE, Austin MB: Serous surface papillary carcinoma. A clinicopathologic study of 10 cases and comparison with stage II-IV ovarian serous carcinoma. Am J Surg Pathol 12:827, 1988.
13. Tobacman JR, Tucker MA, Kase R, et al.: Intrabdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer-prone families. Lancet 2:795, 1982.
14. Raju U, Fine G, Greenwald KA, Ohorodnik JM: Primary papillary serous neoplasia of the peritoneum: A clinicopathologic and ultrastructural study of eight cases. Hum Pathol 20:426, 1989.
15. Chen KTK, Schooley JL, Flam MS: Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome. Obstet Gynecol 66(Suppl):93S, 1985.
16. August CZ, Murad TM, Newton M: Multiple focal extraovarian serous carcinoma. Int J Gynecol Pathol 4:11, 1985.
17. Silva EG, Jenkins R: Serous carcinoma in endometrial polyps. Mod Pathol 3:120, 1990.
18. Lee KR, Belinson JL: Recurrence in noninvasive endometrial carcinoma. Relationship to uterine papillary serous carcinoma. Am J Surg Pathol 15:965, 1991.
19. Lee KR, Belinson JL: Papillary serous adenocarcinoma of the endometrium: A clinicopathologic study of 19 cases. Gynecol Oncol 46:51, 1992.
20. Shermann ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ: Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 16:600, 1992.
21. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R: Uterine papillary serous carcinoma. A highly malignant form of endometrial carcinoma. Am J Surg Pathol 6:93, 1982.
22. Woodruff JD, Julian CG: Multiple malignancy in the upper genital canal. Am J Obstet Gynecol 103:810, 1969.
23. Russell P, Bannatyne PM, Solomon HJ, Stoddard LD, Tattersail MHN: Multifocal tumorigenesis in the upper female genital tract - Implications for staging and management. Int J Gynecol Pathol 4:192, 1985.
24. Pejovic T, Heim S, Mandahl N, et al.: Bilateral ovarian carcinoma: Cytogenetic evidence of unicentric origin. Int J Cancer 47:358, 1991.
25. Mok C-H, Tsao S-W, Knapp RC, Fishbaugh PM, Lau CHC. Unifocal origin of advanced human epithelial ovarian cancers. Cancer Res 52:5119, 1992.
26. Jacobs IJ, Kohler MF, Wiseman RW, et al.: Clonal origin of epithelial ovarian carcinoma: Analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J Natl Cancer Inst 84:1793, 1992.
27. Kottmeier HL (ed): Annual Report on the Treatment of Gynecologic Cancer, Vol 17. Stockholm, Sweden, International Federation of Gynecologists and Obstetricians, 1979.
28. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, Ed 2. New York, Cold Spring Harbor Laboratory Press, 1989.
29. Toguchida J, Yamaguchi T, Dayton SH, et al.: Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 326:1301, 1992.
30. Yandell DW, Dryja TP: Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet 45:547, 1989.
31. Richie JP, Shipley WU, Yagoda A: Cancer of the bladder. In Cancer: Principles and Practices of Oncology, edited by DeVita Jr VT, Hellman S, Rosenberg SA, Vol 1, Ed 3, p 1008. Philadelphia, Lippincott, 1989.
32. Sidransky D, Frost P, Von Eschenbach A, et al.: Clonal origin of bladder cancer. N Engl J Med 326:737, 1992.
33. Worsham MJ, Wolman SR, Carey TE, et al.: Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol 26:251, 1995.
34. Fearon ER, Hamilton SR, Vogelstein B: Clonal analysis of human tumors. Science 238:193, 1987.
35. Mazars R, Pujol P, Maudelonde T, Jeanteur P, Theillet C: p53 mutations in ovarian cancer: A late event? Oncogene 6:1685, 1990.
36. Marks JR, Davidoff AM, Kerns BJ, et al.: Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51:2979, 1991.
37. Okamoto A, Sameshima Y, Yokoyama S, et al.: Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res 51:5171, 1991.
38. Niwa K, Itoh M, Murase T, et al.: Alteration of p53 gene in ovarian carcinoma: Clinicopathological correlation and prognostic significance. Br J Cancer 70:1191-1197, 1994.
39. Milner BJ, Allan LA, Eccles DM, et al.: p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res 53:2128, 1993.
40. Kohler MF, Kerns BJ, Humphrey PA, et al.: Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol 81(5-Part I):643, 1993.
41. Malkin D, Li FP, Strong LC, et al.: Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233, 1990.
42. Kusyk JC, Seski JC, Medlin VW, Edwards LC: Progressive chromosome changes associated with different sites of one ovarian carcinoma. J Natl Cancer Inst 6:1021, 1981.
43. Tanaka T, Bioce CR, Testa JR: Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet 43:1, 1989.
44. Bello MJ, Rey JA: Chromosome aberrations in metastatic ovarian cancer: Relationship with abnormalities in primary tumors. Int J Cancer 45:50, 1990.
45. Chuaqui R, Zhuang Z, Emmert-Buck MR, et al.: Genetic analysis of synchronous tumors of ovary and appendix to determine site of origin (abstract). Mod Pathol 8:87A, 1995.
46. Steinhoff MM, King TC: Synchronous small cell and endometrioid carcinomas of common clonal origin (abstract). Mod Pathol 8:97A, 1995.